BackEncompass Health Overview

Encompass Health EBIT

Track Encompass Health's EBIT ($920M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$294.40M
10.18% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$921.80M
3.08% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Encompass Health (EHC) FAQ

As of the most recent data (June 2026), EHC shows a EBIT of $920M. That compares with $950M in the prior-year period — down 3.1% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EHC's EBIT is now $920M (was $950M) — a 3.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Encompass Health is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Encompass Health is at $920M, which is lower that average. That is roughly 96.0% below the sector mean. Use the comparison chart on this page to see how EHC stacks up against individual peers as well.

Tracking EHC's ebit over time shows whether Encompass Health is scaling, shrinking, or reshaping that part of the business. The current reading is $920M That compares with $950M in the prior-year period — down 3.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Encompass Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $920M) with ownership activity and broader fundamentals.